Department of Industrial Pharmacy, Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku, Nagoya, Aichi 468-8503, Japan.
Int J Pharm. 2011 Feb 28;405(1-2):218-27. doi: 10.1016/j.ijpharm.2010.12.013. Epub 2010 Dec 16.
Simple and easy methods to prepare oral nanosuspension of a poorly water-soluble pharmaceutical candidate compound, called a candidate, have been developed to support the discovery and preclinical studies using animals. The different wet-milling processes in miniature, middle and large preparation scales have been established in order to cover the various types of studies with wide scale. The powder of phenytoin, a poorly water-soluble model drug candidate, was suspended in the aqueous medium, in which the appropriate dispersing agents were dissolved, and milled by agitating together with small hard beads made of zirconia. Three general-purpose equipments with stirring, oscillating and turbulent motions were applied instead of the specific milling machine with high power to avoid much investment at such early development stage. The operational condition and dispersing agents were optimized to obtain finer particles using the middle-scaled oscillating beads-milling apparatus in particular. It was found that the nanosuspension, which whole particle distribution was in the submicron range, was successfully produced within the running time around 10min. By applying the newly developed dispersing medium, the nanoparticles with identical size distribution were also prepared using the stirring and turbulent methods on miniature and large scales, respectively; indicating only 50mg to 30g or more amount of candidate could be milled to nanosuspension using three equipments. The crystalline analysis indicated that the both crystal form and crystallinity of the original bulk drug completely remained after wet-milling process. The results demonstrated that the wet-milling methods developed in this research would be a fundamental technique to produce nanosuspension for poorly water-soluble and oral absorbable drug candidates.
已经开发出简单易用的方法来制备一种水溶性差的药物候选化合物的口服纳米混悬剂,称为候选物,以支持使用动物进行发现和临床前研究。已经建立了从小型、中型和大型制备规模的不同湿法研磨工艺,以涵盖各种类型的广泛规模的研究。将苯妥英(一种水溶性差的模型药物候选物)的粉末悬浮在含有适当分散剂的水性介质中,并通过与由氧化锆制成的小硬珠一起搅拌来研磨。为避免在早期开发阶段投入过多资金,使用具有搅拌、振荡和湍流运动的三种通用设备代替具有高功率的专用研磨机。通过优化操作条件和分散剂,特别是使用中型振荡珠研磨仪来获得更细的颗粒。结果发现,整个颗粒分布在亚微米范围内的纳米混悬剂可以在 10min 左右的运行时间内成功制备。通过应用新开发的分散介质,使用搅拌和湍流方法在微型和大型设备上也分别制备出具有相同粒径分布的纳米颗粒;表明使用三种设备可以将 50mg 至 30g 或更多量的候选物研磨成纳米混悬剂。晶体分析表明,湿磨过程后原始块状药物的晶体形态和结晶度完全保留。结果表明,本研究中开发的湿磨方法将成为制备水溶性差和口服可吸收药物候选物的纳米混悬剂的基础技术。